Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,980 | 1,010 | 13:43 | |
0,980 | 1,010 | 13:17 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Zentek Ltd: Zentek continues preparing for ZenGuard rollout | 1 | Stockwatch | ||
Do | Zentek Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
Do | Zentek Ltd.: Zentek Provides ZenGUARD Business Update | 964 | ACCESSWIRE | GUELPH, ON / ACCESSWIRE / April 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased... ► Artikel lesen | |
03.04. | Zentek Ltd: Zentek signs distribution deal for ZenGuard in U.S. | 3 | Stockwatch | ||
03.04. | Zentek Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
03.04. | Zentek Ltd.: Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions | 382 | ACCESSWIRE | GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce... ► Artikel lesen | |
25.03. | Zentek Ltd: Zentek's Triera touts "promising" C19HBA | 1 | Stockwatch | ||
25.03. | Zentek Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
25.03. | Zentek Ltd.: Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA | 516 | ACCESSWIRE | GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed... ► Artikel lesen | |
30.01. | Zentek Ltd: Zentek sees positive results from C19HBA testing | 2 | Stockwatch | ||
30.01. | Zentek Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
30.01. | Zentek Ltd.: Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA | 1.031 | ACCESSWIRE | GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera")has completed... ► Artikel lesen | |
22.01. | Zentek Ltd: Zentek completes ZenGuard study on energy savings | 2 | Stockwatch | ||
19.01. | Zentek Ltd: Zentek appoints Wallman as chairman; Dube resigns | 1 | Stockwatch | ||
19.01. | Zentek Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
19.01. | Zentek Ltd.: Zentek Announces Eric Wallman Appointed as Chairman of the Board | 905 | ACCESSWIRE | GUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that effective... ► Artikel lesen | |
13.12.23 | Zentek Ltd: Zentek launches subsidiary Triera for aptamer tech | 2 | Stockwatch | ||
13.12.23 | Zentek Ltd.: Zentek Launches Triera Biosciences Ltd. | 1.174 | ACCESSWIRE | GUELPH, ON / ACCESSWIRE / December 13, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces... ► Artikel lesen | |
08.12.23 | Zentek Ltd: Zentek signs ZenGUARD distribution deal with 1Click | 3 | Stockwatch | ||
08.12.23 | Zentek Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 39,750 | +0,13 % | EQS-News: Formycon AG: Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2023 ein und gibt Teilnahme an internationalen Investorenkonferenzen im 2. Quartal 2024 bekannt | EQS-News: Formycon AG
/ Schlagwort(e): Konferenz/Jahresergebnis
Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2023 ein und gibt Teilnahme an internationalen... ► Artikel lesen | |
KOPIN | 0,776 | +2,44 % | Kopin Says Jury Awards Damages Of About $24.8 Mln To BlueRadios | WASHINGTON (dpa-AFX) - Kopin Corp., Inc. (KOPN) announced Tuesday that a jury verdict was entered on Monday in the U.S. District Court for the District of Colorado finding for the plaintiff... ► Artikel lesen | |
RIBER | 2,680 | -0,37 % | Riber: 2024 first quarter revenues: +20% | 2024 first quarter revenues: +20% Order book at the end of March 2024: +4% Bezons, April 26, 2024 - 8:00am (CET) - RIBER, the global leader for molecular beam epitaxy (MBE) equipment serving the semiconductor... ► Artikel lesen | |
VEECO INSTRUMENTS | 31,800 | 0,00 % | Veeco Instruments Inc.: Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results | Fourth Quarter 2023 Highlights: Revenue of $173.9 million, compared with $153.8 million in the same period last yearGAAP net income of $21.6 million, or $0.37 per diluted share, compared with $128.9... ► Artikel lesen | |
ACACIA RESEARCH | 4,480 | -0,88 % | Acacia Research Reports Fourth Quarter 2023 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three months and full year ended December 31, 2023.
Martin... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,515 | +1,98 % | ADVANCE ZINCTEK LIMITED: US Sales | ||
LEHNER INVESTMENTS | 0,064 | -28,49 % | EQS-News: LEHNER INVESTMENTS AG - Neuer Vorstand, Wechsel im Aufsichtsrat | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Personalie
LEHNER INVESTMENTS AG - Neuer Vorstand, Wechsel im Aufsichtsrat
24.04.2024 / 11:24 CET/CEST
Für den Inhalt... ► Artikel lesen | |
NANOFOCUS | 0,300 | 0,00 % | Nanofocus: Investor verlängert die Frist | Die Carl Mahr Holding hat im März ein freiwilliges öffentliches Erwerbsangebot für die Aktien von Nanofocus abgegeben. Geboten werden dabei 0,50 Euro je Aktie von Nanofocus. Ursprünglich konnten Investoren... ► Artikel lesen | |
DOTZ NANO | 0,070 | +6,11 % | DOTZ NANO LIMITED: Change of Auditor | ||
NANOVIRICIDES | 1,010 | -2,88 % | NanoViricides, Inc.: NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon | SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly... ► Artikel lesen | |
GOMSPACE | 0,352 | 0,00 % | GomSpace A/S: GomSpace receives order for cutting-edge products from diverse customers at a total value of €923.000 (approx. 10.8MSEK) | STOCKHOLM, Oct. 31, 2023 /PRNewswire/ -- GomSpace gives an update on its product business and announces that the company has received, since the last press release on September 21, new product... ► Artikel lesen | |
REGION GROUP | 1,278 | 0,00 % | REGION GROUP: Change in substantial holding | ||
XTPL | 31,300 | -1,57 % | EQS-News: XTPL S.A.: XTPL baut industriellen Prototyp eines Geräts zusammen mit führendem chinesischen Hersteller von Maschinen für die Flachbildschirm-Branche | Emittent / Herausgeber: XTPL S.A.
/ Schlagwort(e): Sonstiges
XTPL baut industriellen Prototyp eines Geräts zusammen mit führendem chinesischen Hersteller von Maschinen für die... ► Artikel lesen | |
NANOFORM FINLAND | 2,000 | -7,41 % | NANOFORM: Disclosure of Major Holdings under Law 163/2024 | ||
INSPLORION | 0,203 | +1,50 % | Nasdaq Stockholm AB: New equity rights for trading, Insplorion AB (publ) (625/23) | At the request of Insplorion AB (publ), equity rights will be traded on First
North as from December 5, 2023.
Security name: Insplorion AB TO2
Short name: INSP TO2
ISIN code: SE0020999175... ► Artikel lesen |